StemCell Institute, Oct-Dec (3Q) Ordinary Profit Decreases by 27%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Feb 13, 2025 3:30 pm JST Earnings

7096 StemCell Institute 【J-GAAP】

Earnings Report

StemCell Institute <7096> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was 367 million yen, a 2.5% increase compared to the same period last year. However, the progress rate toward the full-year plan of 600 million yen was 61.2%, also falling below the four-year average of 87.2%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the January to March period (4Q) is expected to surge 3.9 times that of the same period last year, reaching 233 million yen.

In the most recent three-month period, from October to December (3Q), the ordinary profit decreased to 103 million yen, a 27.5% decrease compared to the same period last year. The operating profit margin decreased from 21.0% in the same period last year to 15.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	1,579	261	263	172	16.8	87.7	Feb 7, 2023	J-GAAP
Apr - Dec, 2023	1,884	356	358	254	24.9	85.9	Feb 7, 2024	J-GAAP
Apr - Dec, 2024	2,040	358	367	339	33.2	61.2	Feb 13, 2025	J-GAAP
YoY	+8.3%	+0.6%	+2.5%	+33.5%	+33.4%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	1,268	198	201	151	14.8	0	May 14, 2024	J-GAAP
Oct - Mar, 2024 Guidance	1,627	342	336	229	22.4	0	Nov 12, 2024	J-GAAP
YoY	+28.3%	+72.7%	+67.2%	+51.7%	+51.4%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,091	297	300	198	19.3	0	May 11, 2023	J-GAAP
Mar, 2024	2,481	413	417	310	30.4	0	May 14, 2024	J-GAAP
Mar, 2025 Guidance	3,000	600	600	500	48.9	25	May 14, 2024	J-GAAP
YoY	+20.9%	+45.3%	+43.9%	+61.3%	+61.0%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	671	141	142	95	9.3	21.0	Feb 7, 2024	J-GAAP
Jan - Mar, 2024	597	57	59	56	5.5	9.5	May 14, 2024	J-GAAP
Apr - Jun, 2024	678	123	124	178	17.4	18.1	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	695	135	140	93	9.1	19.4	Nov 12, 2024	J-GAAP
Oct - Dec, 2024	667	100	103	68	6.7	15.0	Feb 13, 2025	J-GAAP
YoY	-0.6%	-29.1%	-27.5%	-28.4%	-28.5%